Velarion Records
Free. Unsubscribe any time.

Wave Life Sciences, Inc. (WVE)

Wave Life Sciences, Inc. filed 23 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 51 transactions and 1,535,070 shares. 23 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Wave Life Sciences, Inc. 51

Adoption dates in Wave Life Sciences, Inc. 7

Results prints in Wave Life Sciences, Inc. 8

Trades before a print in Wave Life Sciences, Inc. 2

Interval to Wave Life Sciences, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Wave Life Sciences, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on August 21, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.